Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 2/20 | 0.37 |
| ▸ | RBP4 | P02753 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12134118 | 0.85 | ALDH1A1 (0.32) | ALDH1A1KMT2AGAA | |
| SCHEMBL12430202 | 0.85 | DPP4 (0.36) | ALDH1A1L3MBTL1PKMNPSR1TSHR | |
| SCHEMBL111708 | 0.84 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1KMT2ALMNA | |
| SCHEMBL13241926 | 0.80 | ALDH1A1 (0.40) | ALDH1A1L3MBTL1PKMRBP4NPSR1 | |
| SCHEMBL11966903 | 0.76 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1PKMNPSR1KMT2A | |
| SCHEMBL7454685 | 0.76 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1PKMRBP4NPSR1 | |
| SCHEMBL6829593 | 0.76 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1PKMRBP4KMT2A | |
| SCHEMBL13995725 | 0.75 | DPP4 (0.31) | — | |
| SCHEMBL5419562 | 0.75 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1PKMRBP4NPSR1 | |
| SCHEMBL7463794 | 0.75 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1PKMRBP4NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8431330-B2 | Surface-treating agent for pattern formation and pattern-forming method using the surface-treating agent | FUJIFILM CORPORATION (JP) | 2013-04-30 | — | — | US | disclosed |
| US-20120076991-A1 | SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT | FUJIFILM CORPORATION (JP) | 2012-03-29 | — | — | US | disclosed |
| US-8088566-B2 | Photoresists; using compound containing an orgaooxygen or organosulfur compound | FUJIFILM CORPORATION (JP) | 2012-01-03 | — | — | US | disclosed |
| US-20100028803-A1 | SURFACE TREATING AGENT FOR RESIST PATTERN FORMATION, RESIST COMPOSITION, METHOD OF TREATING SURFACE OF RESIST PATTERN THEREWITH AND METHOD OF FORMING RESIST PATTERN | FUJIFILM CORPORATION (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20090280440-A1 | SURFACE TREATING AGENT FOR RESIST-PATTERN, AND PATTERN-FORMING METHOD USING SAME | FUJIFILM CORPORATION (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20080241742-A1 | SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080241742-A1 | SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT | KRT18, FSCN1, SLC11A2 | ALDH1A1 445/4885L3MBTL1 4576/4885PKM 3959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.